Section of Interventional Radiology, Department of Radiology, Penn Presbyterian Medical Center, Perelman School of Medicine, University of Pennsylvania, 39th and Market Streets, Philadelphia, PA, 19104, USA.
Division of Vascular Surgery, Department of Surgery, Penn Presbyterian Medical Center, University of Pennsylvania, 39th and Market Streets, Philadelphia, PA, 19104, USA.
Cardiovasc Intervent Radiol. 2019 Aug;42(8):1080-1087. doi: 10.1007/s00270-019-02223-8. Epub 2019 Apr 17.
To assess a novel tibial artery perfusion score (TPS) for predicting limb salvage in critical limb ischemia (CLI) patients undergoing percutaneous vascular intervention (PVI).
A consecutive cohort of 115 CLI patients undergoing PVI in 144 limbs from 2011 to 2016 was analyzed. TPS comprised a 27-point scale based on: (1) patent tibial vessels following PVI, (2) severity of calcification of the tibial arteries, (3) presence of an intact pedal arch following intervention, (4) whether or not revascularization was direct or indirect based on the target angiosome, (5) presence of angiosome blush at the completion of index intervention. Limbs were stratified into (1) High [21-27 points], (2) Medium [13-20 points], and (3) Low [0-12 points] TPS. Predictive value of TPS was evaluated using logistic regression and Cox proportional hazards models.
The median follow-up was 15.7 months (range 0.4-69.9 months). Limb salvage in High, Medium, and Low TPS groups was 90.6%, 85.9%, and 55.6%, respectively, as freedom from the composite outcome: (1) limb complication resulting in death, (2) tibial bypass surgery, (3) above-the-knee amputation, or (4) below-the-knee amputation in patients without supratibial disease at the time of PVI. TPS was significantly associated with limb salvage defined as freedom from both the composite outcome and major amputation.
Based on this preliminary investigation, TPS was associated with limb salvage in CLI limbs, particularly in high-risk limbs. Further validation in a prospective cohort may identify patients with high-risk limbs in need of closer surveillance and earlier reintervention.
Level IV, case series.
评估一种新的胫骨动脉灌注评分(TPS),用于预测接受经皮血管介入治疗(PVI)的严重肢体缺血(CLI)患者的肢体存活情况。
对 2011 年至 2016 年间 115 例 CLI 患者的 144 肢行 PVI 的连续队列进行了分析。TPS 由以下 27 个评分组成:(1)PVI 后胫骨血管通畅,(2)胫骨动脉钙化严重程度,(3)介入后足弓完整,(4)基于靶血管分布区的血运重建是直接还是间接,(5)指数干预完成时是否存在血管分布区显影。肢体分为(1)高[21-27 分],(2)中[13-20 分]和(3)低[0-12 分] TPS。采用逻辑回归和 Cox 比例风险模型评估 TPS 的预测价值。
中位随访时间为 15.7 个月(0.4-69.9 个月)。高、中、低 TPS 组的肢体存活率分别为 90.6%、85.9%和 55.6%,复合终点为:(1)导致死亡的肢体并发症,(2)胫骨旁路手术,(3)膝上截肢,或(4)PVI 时无胫部疾病患者的膝下截肢。TPS 与肢体存活(定义为复合终点和主要截肢的无事件)显著相关。
基于这项初步研究,TPS 与 CLI 肢体的肢体存活相关,特别是在高危肢体中。前瞻性队列研究的进一步验证可能会发现需要更密切监测和更早再介入的高危肢体患者。
四级,病例系列。